<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0006048'>Pulmonary regurgitation</z:mp> (PR) is a frequent sequelae after repair of <z:hpo ids='HP_0001636'>tetralogy of Fallot</z:hpo>, <z:hpo ids='HP_0004935'>pulmonary atresia</z:hpo>, <z:hpo ids='HP_0001660'>truncus arteriosus</z:hpo>, Rastelli and Ross operation </plain></SENT>
<SENT sid="1" pm="."><plain>Due to patient growth and conduit degeneration, these conduits have to be changed frequently due to regurgitation or stenosis </plain></SENT>
<SENT sid="2" pm="."><plain>However, morbidity is significant in these repeated operations </plain></SENT>
<SENT sid="3" pm="."><plain>To prolong conduit longevity, bare-metal stenting in the right ventricular outflow tract (RVOT) obstruction has been performed </plain></SENT>
<SENT sid="4" pm="."><plain>Stenting the RVOT can reduce the right ventricular pressure and symptomatic improvement, but it causes PR with detrimental effects on the right ventricle function and risks of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Percutaneous pulmonary valve implantation has been shown to be a safe and effective treatment for patients with <z:mp ids='MP_0006048'>pulmonary valve insufficiency</z:mp>, or stenotic RVOTs </plain></SENT>
</text></document>